Niels Peterse

Learn More
OBJECTIVE Vascular endothelial growth factor receptor 2 (VEGFR2)-overexpressing cells may form an interesting target for the treatment of atherosclerosis because of their involvement in processes that contribute to this disease, such as angiogenesis. METHODS AND RESULTS We vaccinated mice against VEGFR2 by an orally administered DNA vaccine, comprising a(More)
  • 1